ID   TGBR3_RAT               Reviewed;         853 AA.
AC   P26342;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=Transforming growth factor beta receptor type 3;
DE            Short=TGF-beta receptor type 3;
DE            Short=TGFR-3;
DE   AltName: Full=Betaglycan;
DE   AltName: Full=Transforming growth factor beta receptor III;
DE            Short=TGF-beta receptor type III;
DE   Flags: Precursor;
GN   Name=Tgfbr3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=1657406; DOI=10.1016/0092-8674(91)90073-8;
RA   Lopez-Casillas F., Cheifetz S., Doody J., Andres J.L., Lane W.S.,
RA   Massague J.;
RT   "Structure and expression of the membrane proteoglycan betaglycan, a
RT   component of the TGF-beta receptor system.";
RL   Cell 67:785-795(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 378-388 AND 427-434.
RX   PubMed=1657407; DOI=10.1016/0092-8674(91)90074-9;
RA   Wang X.-F., Lin H.Y., Ng-Eaton E., Downward J., Lodish H.F., Weinberg R.A.;
RT   "Expression cloning and characterization of the TGF-beta type III
RT   receptor.";
RL   Cell 67:797-805(1991).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 591-763, GLYCOSYLATION AT ASN-591
RP   AND ASN-698, DISULFIDE BONDS, AND FUNCTION.
RX   PubMed=21402931; DOI=10.1073/pnas.1010689108;
RA   Lin S.J., Hu Y., Zhu J., Woodruff T.K., Jardetzky T.S.;
RT   "Structure of betaglycan zona pellucida (ZP)-C domain provides insights
RT   into ZP-mediated protein polymerization and TGF-beta binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:5232-5236(2011).
CC   -!- FUNCTION: Binds to TGF-beta. Could be involved in capturing and
CC       retaining TGF-beta for presentation to the signaling receptors
CC       (PubMed:21402931). In gonadotrope cells, acts as an inhibin A
CC       coreceptor and regulates follicle-stimulating hormone (FSH) levels and
CC       female fertility (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:O88393, ECO:0000269|PubMed:21402931}.
CC   -!- SUBUNIT: Interacts with DYNLT4. {ECO:0000250|UniProtKB:Q03167}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305|PubMed:1657406};
CC       Single-pass type I membrane protein {ECO:0000255}. Secreted
CC       {ECO:0000269|PubMed:1657406}. Secreted, extracellular space,
CC       extracellular matrix {ECO:0000305|PubMed:1657406}. Note=Exists both as
CC       a membrane-bound form and as soluble form in serum and in the
CC       extracellular matrix. {ECO:0000305|PubMed:1657406}.
CC   -!- PTM: Extensively modified by glycosaminoglycan groups (GAG).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M77809; AAA40813.1; -; mRNA.
DR   EMBL; M80784; AAA42236.1; -; mRNA.
DR   PIR; A41220; A41220.
DR   RefSeq; NP_058952.1; NM_017256.1.
DR   PDB; 3QW9; X-ray; 2.00 A; A/B=591-763.
DR   PDB; 8DC0; X-ray; 1.93 A; A=590-757.
DR   PDBsum; 3QW9; -.
DR   PDBsum; 8DC0; -.
DR   AlphaFoldDB; P26342; -.
DR   SMR; P26342; -.
DR   DIP; DIP-6248N; -.
DR   STRING; 10116.ENSRNOP00000002867; -.
DR   GlyCosmos; P26342; 8 sites, No reported glycans.
DR   GlyGen; P26342; 8 sites.
DR   iPTMnet; P26342; -.
DR   PhosphoSitePlus; P26342; -.
DR   PaxDb; 10116-ENSRNOP00000002867; -.
DR   Ensembl; ENSRNOT00000002867.5; ENSRNOP00000002867.3; ENSRNOG00000002093.5.
DR   Ensembl; ENSRNOT00055042376; ENSRNOP00055034608; ENSRNOG00055024620.
DR   Ensembl; ENSRNOT00060017107; ENSRNOP00060013297; ENSRNOG00060010131.
DR   Ensembl; ENSRNOT00065021353; ENSRNOP00065016513; ENSRNOG00065013029.
DR   GeneID; 29610; -.
DR   KEGG; rno:29610; -.
DR   UCSC; RGD:61821; rat.
DR   AGR; RGD:61821; -.
DR   CTD; 7049; -.
DR   RGD; 61821; Tgfbr3.
DR   eggNOG; ENOG502QWNZ; Eukaryota.
DR   GeneTree; ENSGT00530000063861; -.
DR   HOGENOM; CLU_018613_0_0_1; -.
DR   InParanoid; P26342; -.
DR   OMA; VPQRECV; -.
DR   OrthoDB; 2949260at2759; -.
DR   PhylomeDB; P26342; -.
DR   TreeFam; TF337375; -.
DR   Reactome; R-RNO-1502540; Signaling by Activin.
DR   Reactome; R-RNO-190370; FGFR1b ligand binding and activation.
DR   Reactome; R-RNO-190373; FGFR1c ligand binding and activation.
DR   Reactome; R-RNO-201451; Signaling by BMP.
DR   Reactome; R-RNO-2173789; TGF-beta receptor signaling activates SMADs.
DR   Reactome; R-RNO-9839383; TGFBR3 PTM regulation.
DR   Reactome; R-RNO-9839389; TGFBR3 regulates TGF-beta signaling.
DR   Reactome; R-RNO-9839397; TGFBR3 regulates FGF2 signaling.
DR   Reactome; R-RNO-9839406; TGFBR3 regulates activin signaling.
DR   EvolutionaryTrace; P26342; -.
DR   PRO; PR:P26342; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002093; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; TAS:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0034673; C:inhibin-betaglycan-ActRII complex; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0043235; C:receptor complex; IDA:BHF-UCL.
DR   GO; GO:0048185; F:activin binding; IDA:RGD.
DR   GO; GO:0036122; F:BMP binding; ISO:RGD.
DR   GO; GO:0015026; F:coreceptor activity; ISO:RGD.
DR   GO; GO:0017134; F:fibroblast growth factor binding; IDA:RGD.
DR   GO; GO:0005539; F:glycosaminoglycan binding; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; IDA:BHF-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; ISO:RGD.
DR   GO; GO:0050431; F:transforming growth factor beta binding; IDA:BHF-UCL.
DR   GO; GO:0005024; F:transforming growth factor beta receptor activity; ISO:RGD.
DR   GO; GO:0070123; F:transforming growth factor beta receptor activity, type III; IDA:BHF-UCL.
DR   GO; GO:0005160; F:transforming growth factor beta receptor binding; IDA:BHF-UCL.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:RGD.
DR   GO; GO:0005114; F:type II transforming growth factor beta receptor binding; ISO:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0060561; P:apoptotic process involved in morphogenesis; ISO:RGD.
DR   GO; GO:0001824; P:blastocyst development; ISO:RGD.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0001974; P:blood vessel remodeling; ISO:RGD.
DR   GO; GO:0030509; P:BMP signaling pathway; ISO:RGD.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0060038; P:cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0032963; P:collagen metabolic process; ISO:RGD.
DR   GO; GO:0060318; P:definitive erythrocyte differentiation; ISO:RGD.
DR   GO; GO:0060216; P:definitive hemopoiesis; ISO:RGD.
DR   GO; GO:0060939; P:epicardium-derived cardiac fibroblast cell development; ISO:RGD.
DR   GO; GO:0001837; P:epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0060347; P:heart trabecula formation; ISO:RGD.
DR   GO; GO:0061384; P:heart trabecula morphogenesis; ISO:RGD.
DR   GO; GO:0006955; P:immune response; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0003150; P:muscular septum morphogenesis; ISO:RGD.
DR   GO; GO:1902338; P:negative regulation of apoptotic process involved in morphogenesis; ISO:RGD.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0010633; P:negative regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:1901202; P:negative regulation of extracellular matrix assembly; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0060392; P:negative regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; IDA:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0030513; P:positive regulation of BMP signaling pathway; ISO:RGD.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISO:RGD.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0060391; P:positive regulation of SMAD protein signal transduction; ISO:RGD.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0032354; P:response to follicle-stimulating hormone; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0034699; P:response to luteinizing hormone; ISO:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; ISO:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISO:RGD.
DR   GO; GO:0062009; P:secondary palate development; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; NAS:BHF-UCL.
DR   GO; GO:0007181; P:transforming growth factor beta receptor complex assembly; IMP:RGD.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0001570; P:vasculogenesis; ISO:RGD.
DR   GO; GO:0060979; P:vasculogenesis involved in coronary vascular morphogenesis; ISO:RGD.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0003223; P:ventricular compact myocardium morphogenesis; ISO:RGD.
DR   GO; GO:0060412; P:ventricular septum morphogenesis; ISO:RGD.
DR   Gene3D; 2.60.40.4100; Zona pellucida, ZP-C domain; 1.
DR   Gene3D; 2.60.40.3210; Zona pellucida, ZP-N domain; 1.
DR   InterPro; IPR042235; ZP-C.
DR   InterPro; IPR048290; ZP_chr.
DR   InterPro; IPR001507; ZP_dom.
DR   InterPro; IPR017977; ZP_dom_CS.
DR   PANTHER; PTHR14002; ENDOGLIN/TGF-BETA RECEPTOR TYPE III; 1.
DR   PANTHER; PTHR14002:SF7; TRANSFORMING GROWTH FACTOR BETA RECEPTOR TYPE 3; 1.
DR   Pfam; PF00100; Zona_pellucida; 1.
DR   PRINTS; PR00023; ZPELLUCIDA.
DR   SMART; SM00241; ZP; 1.
DR   PROSITE; PS00682; ZP_1; 1.
DR   PROSITE; PS51034; ZP_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Direct protein sequencing; Disulfide bond;
KW   Extracellular matrix; Glycoprotein; Membrane; Proteoglycan; Receptor;
KW   Reference proteome; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..853
FT                   /note="Transforming growth factor beta receptor type 3"
FT                   /id="PRO_0000041666"
FT   TOPO_DOM        24..789
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        790..811
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        812..853
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          456..730
FT                   /note="ZP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00375"
FT   REGION          530..559
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          737..751
FT                   /note="Interaction with TGF-beta ligand"
FT                   /evidence="ECO:0000250"
FT   REGION          820..853
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        37
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        144
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        493
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        535
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        546
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        572
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21402931"
FT   CARBOHYD        698
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21402931"
FT   DISULFID        640..706
FT                   /evidence="ECO:0000269|PubMed:21402931"
FT   DISULFID        661..730
FT                   /evidence="ECO:0000269|PubMed:21402931"
FT   DISULFID        711..723
FT                   /evidence="ECO:0000250|UniProtKB:O88393"
FT   CONFLICT        164
FT                   /note="L -> V (in Ref. 2; AAA42236)"
FT                   /evidence="ECO:0000305"
FT   STRAND          593..601
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          610..614
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          619..627
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          633..644
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          653..662
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          668..670
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   TURN            678..681
FT                   /evidence="ECO:0007829|PDB:3QW9"
FT   STRAND          685..692
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          700..714
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   TURN            715..717
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          718..720
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   HELIX           726..731
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   HELIX           735..741
FT                   /evidence="ECO:0007829|PDB:8DC0"
FT   STRAND          744..754
FT                   /evidence="ECO:0007829|PDB:8DC0"
SQ   SEQUENCE   853 AA;  94103 MW;  AF7078599560A928 CRC64;
     MAVTSHHMIP VMVVLMSACL ATAGPEPSTR CELSPINASH PVQALMESFT VLSGCASRGT
     TGLPREVHVL NLRSTDQGPG QRQREVTLHL NPIASVHTHH KPIVFLLNSP QPLVWHLKTE
     RLAAGVPRLF LVSEGSVVQF PSGNFSLTAE TEERNFPQEN EHLLRWAQKE YGAVTSFTEL
     KIARNIYIKV GEDQVFPPTC NIGKNFLSLN YLAEYLQPKA AEGCVLPSQP HEKEVHIIEL
     ITPSSNPYSA FQVDIIVDIR PAQEDPEVVK NLVLILKCKK SVNWVIKSFD VKGNLKVIAP
     NSIGFGKESE RSMTMTKLVR DDIPSTQENL MKWALDNGYR PVTSYTMAPV ANRFHLRLEN
     NEEMRDEEVH TIPPELRILL DPDHPPALDN PLFPGEGSPN GGLPFPFPDI PRRGWKEGED
     RIPRPKQPIV PSVQLLPDHR EPEEVQGGVD IALSVKCDHE KMVVAVDKDS FQTNGYSGME
     LTLLDPSCKA KMNGTHFVLE SPLNGCGTRH RRSTPDGVVY YNSIVVQAPS PGDSSGWPDG
     YEDLESGDNG FPGDGDEGET APLSRAGVVV FNCSLRQLRN PSGFQGQLDG NATFNMELYN
     TDLFLVPSPG VFSVAENEHV YVEVSVTKAD QDLGFAIQTC FLSPYSNPDR MSDYTIIENI
     CPKDDSVKFY SSKRVHFPIP HAEVDKKRFS FLFKSVFNTS LLFLHCELTL CSRKKGSLKL
     PRCVTPDDAC TSLDATMIWT MMQNKKTFTK PLAVVLQVDY KENVPSTKDS SPIPPPPPQI
     FHGLDTLTVM GIAFAAFVIG ALLTGALWYI YSHTGETARR QQVPTSPPAS ENSSAAHSIG
     STQSTPCSSS STA
//
